The Centers for Disease Control and Prevention has delayed a vote until Friday on whether to change a longstanding recommendation that newborns should receive the hepatitis B vaccine. Dr. Peter Chin-Hong,

Americans’ confidence in the Centers for Disease Control and Prevention has plummeted, according to a 2025 National Foundation for Infectious Diseases survey, and many young people are

The Centers for Disease Control and Prevention's vaccine advisory panel met Thursday for the first of two days of discussions about childhood vaccine schedules and recommendations. The panel is focusing on the hepatitis B vaccine and plans to vote on whether to continue recommending it be given to all children at birth or delay the first dose.

CDC’s vaccine advisory committee delays Hepatitis B vaccine vote to Friday; Novo Nordisk still banking on potential of GLP-1s to treat Alzheimer’s despite trial setbacks; Mark Cuban urges Trump administration to waive generic approval fees.

The best way to prevent hepatitis B infection is vaccination. The vaccines are highly effective at preventing infection in infants and for long-term protection into adulthood.

For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.

"There are some signs that another big norovirus season is ahead of us," Emory University Professor Ben Lopman told Newsweek.

Senate Health Committee Chair Bill Cassidy criticized the decision to invite Aaron Siri, who worked with Kennedy on vaccine-related lawsuits, to present at the CDC meeting.